UK Cancer Detection Firm CanSense Raises £1.5M for Development of Colorectal Cancer Test (360Dx) 0 By Praveen Suthrum on March 13, 2023 Exponential Tech Share Facebook Twitter LinkedIn Pinterest Email CanSense’s test is a blood-based assay that uses laser spectroscopy and artificial intelligence to identify early-stage colorectal cancer and precancerous polyps. Read More Artificial Intelligence Colorectal Cancer
Outlook Surgical Obtains FDA 510(k) Clearance for Hybrid Endoscope: A Breakthrough in Surgical Visualization (PR Newswire)
World’s First Fully Robotic Procedure by a Gastroenterologist Completed Using EndoQuest’s Endoluminal Surgical System in the PARADIGM Trial (GlobeNewswire)
GutGPT: A multidimensional knowledge-enhanced large language model for gastrointestinal medicine (ScienceDirect)
Spider-inspired magnetic soft robots could perform minimally invasive gastrointestinal tract procedures (Medical Xpress)